Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal...
15 KB (1,291 words) - 21:40, 29 May 2025
Niraparib/abiraterone acetate, sold under the brand name Akeega, is a fixed-dose combination anti-cancer medication used for the treatment of prostate...
11 KB (831 words) - 04:27, 21 April 2025
drug pembrolizumab and PARP inhibitors, namely olaparib, rucaparib, or niraparib. Bone metastases – present in around 85% of those with metastatic prostate...
81 KB (9,190 words) - 21:59, 29 May 2025
full-time employees, 59 of whom had a PhD or MD. The company's product Niraparib was granted priority review and was given a target action date of June...
5 KB (364 words) - 23:58, 12 September 2024
L01XK01 Olaparib L01XK02 Niraparib L01XK03 Rucaparib L01XK04 Talazoparib L01XK05 Veliparib L01XK06 Pamiparib L01XK52 Niraparib and abiraterone L01XL01...
13 KB (932 words) - 04:36, 23 December 2024
BRCA-mutant ovarian cancer. In April 2018 it was granted FDA approval. Niraparib: In March 2017 approved by US FDA for epithelial ovarian, fallopian tube...
24 KB (2,547 words) - 09:11, 31 March 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
22 KB (1,748 words) - 22:20, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
19 KB (1,730 words) - 06:30, 25 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
27 KB (2,332 words) - 22:20, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
13 KB (842 words) - 22:19, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
62 KB (5,613 words) - 21:45, 19 April 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
4 KB (128 words) - 11:38, 22 April 2024
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
72 KB (7,424 words) - 20:51, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
12 KB (878 words) - 20:10, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
7 KB (564 words) - 16:04, 9 January 2024
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
161 KB (15,261 words) - 19:58, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
191 KB (18,328 words) - 22:14, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
25 KB (2,171 words) - 20:01, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
5 KB (210 words) - 06:16, 5 July 2024
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
43 KB (3,691 words) - 22:20, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
34 KB (3,131 words) - 01:44, 25 May 2025
like bevacizumab and PARP inhibitors such as olaparib, rucaparib, and niraparib, which are particularly effective in tumors with specific genetic mutations...
14 KB (1,306 words) - 15:05, 21 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
16 KB (1,289 words) - 20:39, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
21 KB (1,824 words) - 22:05, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
33 KB (3,152 words) - 18:41, 25 April 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
27 KB (2,339 words) - 21:12, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
19 KB (1,557 words) - 22:20, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
40 KB (3,616 words) - 12:21, 23 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
150 KB (15,796 words) - 18:42, 23 May 2025
found to increase sensitivity to PARP inhibitors, such as olaparib and niraparib, offering new treatment avenues. Research into various prognostic factors...
199 KB (21,276 words) - 21:46, 29 May 2025